Price (delayed)
$5.47
Market cap
$386.45M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.68
Enterprise value
$346.25M
Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and
There are no recent dividends present for PSNL.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.